Pyoderma gangrenosum and Behçet's-like disease induced by secukinumab: a paradoxical drug reaction

J Dermatolog Treat. 2023 Dec;34(1):2235040. doi: 10.1080/09546634.2023.2235040.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Behcet Syndrome* / drug therapy
  • Humans
  • Pyoderma Gangrenosum* / chemically induced
  • Pyoderma Gangrenosum* / drug therapy

Substances

  • secukinumab
  • Antibodies, Monoclonal, Humanized